MEDINET
Home Site Map Japanese
Corporate Information About Immuno-Cell Therapy Research and Development Press Release IR Information Inquiaries
Home ≫ Financial Summary
 
To Our Shareholders
Financial Summary
IR Data
IR News
  Financial Report
Stock Price Information (Go to Blooming's Website
  【Latest 5-Year Financial Highlights】
End of Fiscal Year Sep. 2006 Sep. 2007 Sep. 2008 Sep. 2009 Sep. 2010
Sales (JPY' 000)
1,526,930
1,606,986
1,838,469
2,900,215
3,202,490
Operating Income (Loss) (JPY' 000)
(782,535)
(827,528)
(704,418)
323,982
366,270
Net Income (Loss) (JPY' 000)
(821,011)
100,235
(1,702,837)
245,873
438,556
Equity Method Investment Gain (Loss) (JPY' 000)
(19,874)
Paid in Capital (JPY' 000)
2,056,750
2,193,030
2,267,332
2,521,487
2,582,161
Common Shares-Number of Shares Issued (Shares)
556,200
577,720
593,600
625,600
632,755
Net Assets (JPY' 000)
3,764,377
4,088,296
2,588,745
3,317,568
3,855,451
Total Assets (JPY' 000)
4,237,448
4,501,137
2,963,958
3,889,510
5,759,737
Shareholder's Equity per Share (Yen)
6,768.03
7,065.01
4,351.32
5,298.23
6,093.12
Net Income (Loss) per Share (Yen)
(1,479.51)
176.9
(2,889.35)
410.77
693.08
Equity Ratio (%)
88.8
90.7
87.1
85.2
66.9
Return on Equity (%)
(19.7)
2.6
(51.1)
8.4
12.2
Cash Flow from Operating Activities (JPY' 000)
(641,463)
(851,877)
(626,416)
319,602
528,004
Cash Flow from Investing Activities (JPY' 000)
(752,692)
192,059
(253,839)
(587,601)
(73,935)
Cash Flow from Financing Activities (JPY' 000)
5,000
250,468
130,919
501,048
1,112,675
Cash and Equivalents at the End of Fiscal Year (JPY' 000)
2,321,275
1,911,926
1,162,591
1,395,316
2,962,074
Number of Employees (Employees)
130
123
113
122
146
(Average Number of Temporary Employees)
(8)
(13)
(16)
(17)
(22)
Data Financial Highlight Trend in Sales Trend in Income
【Trend in Sales】
Data Financial Highlight Trend in Sales Trend in Income
【Trend in Income】
Data Financial Highlight Trend in Sales Trend in Income
 
       
     
Return to Top
 
MEDINET Co., Ltd.